Myoview 1.38 mg/1

Myoview 1.38 mg/1 is a lyophilized powder for solution, containing tetrofosmin, used for diagnostic imaging. This intravenous injection aids in evaluating cardiac function and blood flow.

Myoview 1.38 mg/1 is primarily used in nuclear medicine for myocardial perfusion imaging. This diagnostic tool helps assess blood flow to the heart muscle, aiding in the evaluation of coronary artery disease. Healthcare professionals may use it to identify areas of reduced blood flow, which can indicate potential heart issues.

When administered intravenously, Myoview 1.38 mg/1 distributes throughout the body and accumulates in the heart muscle. This accumulation allows for clear imaging, helping to highlight areas with adequate or reduced blood flow. The effects are typically observed during imaging procedures.

Myoview 1.38 mg/1 should be handled with care, following standard protocols for radioactive materials. It is essential to use appropriate protective measures to minimize exposure. Always consult healthcare professionals for proper administration and handling guidelines.

Myoview 1.38 mg/1 may interact with other medications or substances, particularly those affecting heart function or blood flow. It is crucial to inform healthcare providers about all current medications to avoid potential interactions. Always follow professional advice regarding concurrent use with other treatments.